Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
626
-
Total 13F shares, excl. options
-
200M
-
Shares change
-
-14.8M
-
Total reported value, excl. options
-
$2.13B
-
Value change
-
-$151M
-
Put/Call ratio
-
1.16
-
Number of buys
-
213
-
Number of sells
-
-302
-
Price
-
$10.68
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q3 2025
733 filings reported holding OGN - Organon & Co. - Common Stock as of Q3 2025.
Organon & Co. - Common Stock (OGN) has 626 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 200M shares
of 260M outstanding shares and own 76.79% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (35.9M shares), BlackRock, Inc. (30.9M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (9.5M shares), STATE STREET CORP (9.34M shares), LSV ASSET MANAGEMENT (7.83M shares), GEODE CAPITAL MANAGEMENT, LLC (4.82M shares), MILLENNIUM MANAGEMENT LLC (4.53M shares), MORGAN STANLEY (4.36M shares), AQR CAPITAL MANAGEMENT LLC (4.18M shares), and Gotham Asset Management, LLC (3.71M shares).
This table shows the top 626 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.